Clinical Trial Update: 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

View source ↗

Summary

A completed two-year real-world study assessing retention, quality of life, effectiveness and treatment patterns of secukinumab in adults with plaque psoriasis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Non-radiographic Axial Spondyloarthritis
• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Status: COMPLETED